Qiagen NV (Qiagen NV) Days Payable : 38.06 (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Days Payable?

Qiagen NV's average Accounts Payable for the three months ended in Dec. 2023 was $81 Mil. Qiagen NV's Cost of Goods Sold for the three months ended in Dec. 2023 was $193 Mil. Hence, Qiagen NV's Days Payable for the three months ended in Dec. 2023 was 38.06.

The historical rank and industry rank for Qiagen NV's Days Payable or its related term are showing as below:

QGEN' s Days Payable Range Over the Past 10 Years
Min: 36.91 Med: 46.24 Max: 58.08
Current: 42.72

During the past 13 years, Qiagen NV's highest Days Payable was 58.08. The lowest was 36.91. And the median was 46.24.

QGEN's Days Payable is ranked worse than
68.57% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: 68.79 vs QGEN: 42.72

Qiagen NV's Days Payable declined from Dec. 2022 (45.91) to Dec. 2023 (38.06). It may suggest that Qiagen NV accelerated paying its suppliers.

Qiagen NV Days Payable Historical Data

The historical data trend for Qiagen NV's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Days Payable Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

53.99

58.08

49.99

48.21

45.62

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															45.91	46.96	42.03	41.24	38.06

Competitive Comparison of Qiagen NV's Days Payable

For the Diagnostics & Research subindustry, Qiagen NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Days Payable distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Days Payable falls into.

Qiagen NV Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Qiagen NV's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (98.734	+	84.155)	/	2 )	/	731.623	*	365
=	91.4445					/	731.623	*	365
=	45.62

Qiagen NV's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (76.887	+	84.155)	/	2 )	/	193.062	*	365 / 4
=	80.521					/	193.062	*	365 / 4
=	38.06

Qiagen NV Days Payable Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Days Payable

Comparable Companies

EXAS NTRA CRL MEDP RVTY RDNT DGX SHC NEOG GH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives